DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Yamamoto T, Tajima Y.
HMGB1 is a promising therapeutic target for acute liver failure.
Expert Rev Gastroenterol Hepatol 2017;
11 (07) 673-682
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.